Company Profile (AI Text)
Name: One Health Biosensing
Canonical URL: https://wefunder.com/one.health.biosensing
Updated at: 2026-06-15T05:01:20Z

Tagline: Over $5B in exits from team creating Razorfish, One Drop, Big Foot, Welldoc, we're re-defining CGM.

Key claims:
- Total raised on Wefunder: 149016 | citation: https://wefunder.com/one.health.biosensing#claim-total-raised
- Total investors: 132 | citation: https://wefunder.com/one.health.biosensing#claim-total-investors

Verified facts:
- Total raised on Wefunder: 149016 | observed_at: 2026-06-15T05:01:20Z | expires_at: 2026-06-16T05:01:20Z
- Total investors: 132 | observed_at: 2026-06-15T05:01:20Z | expires_at: 2026-06-16T05:01:20Z

Computed metrics:
- total_amount_raised: 149016
- total_investors: 132
- team_size: 4
- featured_investor_count: 5
- faq_count: 5
- recent_post_count: 6

Quick facts:
- A multi-modal AI-enabled health sensing platform designed to revolutionize the $10bn CGM market | citation: https://wefunder.com/one.health.biosensing#claim-fact-1
- A low-cost, painless, needle-free solution for >1Bn people with diabetes, pre-diabetes and obesity | citation: https://wefunder.com/one.health.biosensing#claim-fact-2
- Proprietary silicon micro-needle array technology, 10 years in R&D, protected by >50 issued patents | citation: https://wefunder.com/one.health.biosensing#claim-fact-3
- Demonstrated performance in >1,500 hrs of onbody clinical data with an estimated MARD of <10 | citation: https://wefunder.com/one.health.biosensing#claim-fact-4
- Bolstered by >60Bn data points and AI capabilities proven to reduce A1C by 1.9% and weight by >10lbs | citation: https://wefunder.com/one.health.biosensing#claim-fact-5
- Projecting $250M in revenue two years post launch and >$1bn five years post launch (not guaranteed) | citation: https://wefunder.com/one.health.biosensing#claim-fact-6
- Founder and CEO with a proven track record of successful exits and a world class leadership team | citation: https://wefunder.com/one.health.biosensing#claim-fact-7
- Existing investors include RRE, Box Group, FJ Labs, True Ventures, First Round Capital, and others | citation: https://wefunder.com/one.health.biosensing#claim-fact-8

FAQ:
- Q: Is a prescription required for your One Drop CGMs?
  A: Hey Ed, thank you for your note. Yes, the One Health CGM will be a prescription product covered by insurance initially. We may look to OTC and cash pay in the future. I hope this helps and we look forward to staying connected and sharing more updates. Thanks - Jeff Dachis CEO
- Q: How does this compare to dexcom devices? In terms of accuracy and how painful the product is to use?
  A: Hey Noah, thank you for reaching out with insightful questions. 1) Int terms of accuracy, Our device is as accurate as a Dexcom G7, but we are a daily - 1 day - use product and Dexcom is a 10 day use product. We are an order of magnitude lest costly than Dexcom, because we are re-using the applicator, battery, radio, chipset and other expensive components. Lastly, we make the silicon based micro-needle arrays at a wafer scale which means we are producing 1000 sensors at a time vs Dexcom’s wir...
- Q: Can you share your thoughts on how often you will update us on how things are progressing with your goals and business plan? Secondly, do you intend to file the annual report with the SEC? Thanks for your feedback.
  A: Karolina, thank you for reaching out, we appreciate your interest. We will update investors with progress check-ins as we make meaningful progress on our initiatives and hit update worthy milestones. I will also share interesting things about our progress. As an example, we just successfully coated our newest silicon wafers, that we use to mill into micro needles with a new nano-platinum coating and the micron electroscope photos of the newest coating look really cool. I would share those. We...
- Q: How is it minimally invasive when you have to change the site daily and how are the micro-needles able to measure interstitial fluid when the sensor needs to be placed much deeper inside? How does it calibrate and maintain accuracy and how can it be continuous if it needs to b...
  A: Hey Mikaela, thank you for reaching out, your interest in One Health, and your insightful questions. Sensors only sit in the skin 400 microns, less than half a millimeter. It is factory calibrated, as accurate as today’s best sensors and measures glucose every minute for 24-30 hours. The sensor requires ~30 minutes to warm up. As a daily wear model (much like contact lenses) you have flexibility as to when you are sensing. That same daily model provides payers with flexibility in dosing and c...
- Q: Hi Jeff, your page says "protected by >50 issued patents ", but are these patents owned by One Health Biosensing? Or are they owned by some other entity and One Health Biosensing has an exclusive worldwide license covering these, or what. Please be a little more specific fo...
  A: Hey Kim, thanks for the note and the insightful questions. For all the core underlying technology for the CGM sensor, One Health Biosensing owns the patents outright exclusively. For certain other software, etc.. One Health Biosensing has branching licenses to certain patents owned by our previous company. Happy to answer more questions as they come up! - Jeff

Recent posts:
- **CLOSING TODAY** Final opportunity to increase/invest in AI-enabled CGM (2025-04-30T14:16:29Z) https://wefunder.com/feed/182028
- LAST DAY TO INVEST - TODAY (2025-04-29T15:27:26Z) https://wefunder.com/feed/181978
- **FINAL 2 DAYS** to invest in the future of diabetes care (Hint - its micro needles) (2025-04-28T14:42:53Z) https://wefunder.com/feed/181900
- We didn’t invent CGM, but we are re-defining it. (2025-04-23T16:55:40Z) https://wefunder.com/feed/181745
- ** 9 days left - to invest in the future of CGM ** (2025-04-21T20:28:18Z) https://wefunder.com/feed/181648
- 20 Days left to invest in One Health Biosensing's Community Round! (2025-04-11T14:41:05Z) https://wefunder.com/feed/181347